FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813. II. In vitro property and mode of action

Journal of Antibiotics

Volumn 56, Issue 2, 2003, Pages 62-67

  Fujine, Kiyotaka ^a   Abe, Fumie ^a   Seki, Nobuo ^a   Ueda, Hirotsugu ^a   Hino, Motohiro ^a   Fujii, Takashi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; FR 252921; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; TACROLIMUS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIUM CULTURE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; PURIFICATION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

PSEUDOMONAS FLUORESCENS;

EID: 0037300511     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.62     Document Type: Article

References (20)

1. RUEGGER, A.; M. KUHN, H. LICHTI, H. R. LOOSLI, R. HUGUENIN, C. QUIQUEREZ & A. VON WARTBURG: Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity. Helv. Chim. Acta. 59: 1075-1092, 1976
2. KINO, T.; H. HATANAKA, S. MIYATA, N. INAMURA; M. NISHIYAMA, T. YAJIMA, T. GOTO, M. OKUHARA, M. KOHSAKA & H. AOKI: FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiotics 40: 1256-1265, 1987
3. TAKEMOTO, S. K.: Maintenance immunosuppression. Clin. Transpl.: 223-236, 2001
4. FUJINE, K.; M. TANAKA, K. OHSUMI, M. HASHIMOTO, S. TAKASE, H. UEDA, M. HINO & T. FUJII: FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens No. 408813. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities of FR252921, FR25922 and FR256523. J. Antibiotics 56: 55-61, 2003
5. GRANELLI-PIPERNO, A. & P. NOLAN: Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells. J. Immunol. 147: 2734-2739, 1991
6. ZHU, C.; K. GAGNIDZE, J. H. GEMBERLING & S. E. PLEVY: Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J. Biol. Chem. 276: 18519-18528, 2001
7. NEWELL, C. L.; A. B. DEISSEROTH & G. LOPEZ-BERESTEIN: Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. J. Leukoc. Biol. 56: 27-35, 1994
8. OHLSSON, B. G.; M. C. ENGLUND, A. L. KARLSSON, E. KNUTSEN, C. ERIXON, H. SKRIBECK, Y. LIU, G. BONDJERS & O. WIKLUND: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J. Clin. Invest. 98: 78-89, 1996
9. SCHREIBER, S. L.: Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287, 1991
10. CLIPSTONE, N. A. & G. R. CRABTREE: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697, 1992
11. ZHU, C.; K. GAGNIDZE, J. H. GEMBERLING & S. E. PLEVY: Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J. Biol. Chem. 276: 18519-18528, 2001
12. FUJIHARA, M.; M. MUROI, Y. MUROI, N. ITO & T. SUZUKI: Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J. Biol. Chem. 268: 14898-14905, 1993
13. PHUCHAREON, J. & T. TOKUHISA: Deregulated c-Fos/AP-1 accelerates cell cycle progression of B lymphocytes stimulated with lipopolysaccharide. Immunobiology 193: 391-399, 1995
14. PHUCHAREON, J. & T. TOKUHISA: Deregulated c-Fos/AP-1 modulates expression of the cyclin and the cdk gene in splenic B cells stimulated with lipopolysaccharide. Cancer Lett. 92: 203-208, 1995
15. MANN, J.; F. OAKLEY, P. W. JOHNSON & D. A. MANN: CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, and CBF1. J. Biol. Chem. 277: 17125-17138, 2002
16. JAIN, J.; P. G. MCCAFFREY, Z. MINER, T. K. KERPPOLA, J. N. LAMBERT, G. L. VERDINE, T., CURRAN & A. RAO: The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352-355, 1993
17. JAIN, J.; P. G. MCCAFFREY, V. E. VALGE-ARCHER & A. RAO: Nuclear factor of activated T cells contains Fos and Jun. Nature 356: 801-804, 1992
18. BAID, S.; S. L. SAIDMAN, N. TOLKOFF-RUBIN, W. W. WILLIAMS, F. L. DELMONICO, A. B. COSIMI & M. PASCUAL: Managing the highly sensitized transplant recipient and B cell tolerance. Curr. Opin. Immunol. 13: 577-581, 2001
19. SHORTMAN, K. & Y. J. LIU: Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161, 2002
20. FUJINE, K.; H. UEDA, M. HINO & T. FUJII: FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens No. 408813. III. In vivo activities. J. Antibiotics 56: 68-71, 2003